Search results for "Highlights"
In patients with type 2 diabetes or HF, SGLT2 inhibitors reduce gout-related outcomes
The effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on gout in patients with type 2 diabetes or heart failure (HF) may allow reduced polypharmacy when treatment for gout is also needed, an ACP Journal Club commentary said.
https://diabetes.acponline.org/archives/2023/11/10/6.htm
10 Nov 2023
Monofilament test for diagnosing diabetic polyneuropathy has high rate of false negatives
A Norwegian study found that the 5.07/10-g monofilament test was less sensitive in women and in older patients and less specific in patients with neuropathic pain. The study's authors recommended against using the monofilament test to diagnose diabetic polyneuropathy.
https://diabetes.acponline.org/archives/2023/12/08/1.htm
8 Dec 2023
Update in Endocrinology highlights top diabetes research of 2013
Ten studies from 2013 with potential to change endocrinology practice were summarized in Annals of Internal Medicine's annual Update in Endocrinology, published in the June 3 issue.
https://diabetes.acponline.org/archives/2014/06/13/5.htm
13 Jun 2014
CT as effective as angiography as first test for patients with diabetes, chest pain
Patients with diabetes and stable chest pain had no difference in major adverse cardiac events if they underwent cardiac CT first when they were referred for invasive coronary angiography, and they had fewer procedure-related complications with a CT-first strategy.
https://diabetes.acponline.org/archives/2023/10/13/2.htm
13 Oct 2023
COVID-19 boosters associated with transient increases in glycemia, study finds
A small cohort study of patients with type 1 diabetes who received COVID-19 booster vaccines found significant increases in their blood glucose levels on the second and third day after vaccination.
https://diabetes.acponline.org/archives/2023/10/13/3.htm
13 Oct 2023
Higher aspirin dose no more effective for CV prevention in high-risk patients with diabetes
A subgroup analysis of a randomized trial found that patients with diabetes and atherosclerotic cardiovascular (CV) disease had similar outcomes whether they took 81 mg or 325 mg of aspirin daily.
https://diabetes.acponline.org/archives/2023/10/13/10.htm
13 Oct 2023
Diabetes patients lost more weight with time-restricted eating than calorie counting
Over the course of six months, eating only between noon and 8 p.m. had a greater impact on weight loss and a similar effect on HbA1c levels compared with reducing energy intake by 25%, according to a small randomized trial of patients with type 2 diabetes and obesity.
https://diabetes.acponline.org/archives/2023/11/10/1.htm
10 Nov 2023
New international guidelines tackle diabetic foot infection diagnosis, treatment
Recommendations from the International Working Group on the Diabetic Foot and the Infectious Diseases Society of America focus on diagnosing soft-tissue and bone infection and choosing when to give antibiotics, among other topics.
https://diabetes.acponline.org/archives/2023/10/13/1.htm
13 Oct 2023
Portable point-of-care screening may help improve diabetic retinopathy diagnosis
An Australian study found that 39.6% of patients at high-risk diabetes clinics had diabetic retinopathy and 15.8% had vision-threatening diabetic retinopathy, previously undiagnosed in 59.3% and 62.8%, respectively.
https://diabetes.acponline.org/archives/2023/09/08/3.htm
8 Sep 2023
Liraglutide shows some benefits as adjunctive therapy in type 1 diabetes, review finds
A systematic review and meta-analysis of studies involving four glucagon-like peptide-1 receptor agonists found that liraglutide had the greatest effect on HbA1c level, weight, and total insulin dose, although odds of nausea and ketosis were higher.
https://diabetes.acponline.org/archives/2023/09/08/2.htm
8 Sep 2023